MedPath
NMPA Approval

Buprenorphine Transdermal Patches

国药准字HJ20181111

November 16, 2022

H20181111

Drug Information

丁丙诺啡透皮贴剂

贴剂

5mg/贴

化学药品

November 16, 2022

November 15, 2027

Company Information

Applicant Company

Mundipharma GmbH

De Saint-Exupéry-Straβe 10, 60549 Frankfurt am Main,Germany

Manufacturing Company

Lohmannstr. 2,D–56626 Andernach,Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

丁丙诺啡透皮贴剂 - NMPA 批准文号 | MedPath